Elevai Labs, Inc. (NASDAQ:ELAB – Get Free Report) shares dropped 2.4% on Tuesday . The stock traded as low as $1.66 and last traded at $1.66. Approximately 349,289 shares traded hands during mid-day trading, a decline of 89% from the average daily volume of 3,079,531 shares. The stock had previously closed at $1.70.
Elevai Labs Price Performance
The company has a market capitalization of $5.10 million, a P/E ratio of -0.03 and a beta of -3.28. The company’s 50-day moving average price is $2.11 and its two-hundred day moving average price is $20.30. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.86 and a quick ratio of 3.40.
Elevai Labs Company Profile
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.
Further Reading
- Five stocks we like better than Elevai Labs
- Compound Interest and Why It Matters When Investing
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Elevai Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevai Labs and related companies with MarketBeat.com's FREE daily email newsletter.
